COVID Boosters Are Critical, But Using Only Animal Data Is a Needless Gamble

FDA’s reliance on animal-tested data ahead of a planned Fall 2022 booster rollout is nothing short of cutting corners.

Related Keywords

United States ,White House ,District Of Columbia ,Ashish Jha ,Centers For Disease ,Methods Program ,Drug Administration ,International Coalition Of Medicines Regulatory Authorities ,Coordinator Ashish Jha ,Disease Control ,International Coalition ,Medicines Regulatory Authorities ,Microphysiological Systems ,World Summit ,Predictive Toxicology Roadmap ,New Alternative Methods Program ,